Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MiNK Therapeutics Inc. Common Stock
INKT | US
10.95
USD0.22
2.05%
INKT | US
Loading StockChartView...
About MiNK Therapeutics Inc. Common Stock
Sector
1840229
Industry
1840229
Earnings date
30/06/2024
As of date
24/04/2026
Close
10.95
Open
10.72
High
11.51
Low
10.43
MiNK Therapeutics Inc. a clinical stage biopharmaceutical company engages in the discovery development and commercialization of allogeneic off-the-shelf invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797 an off-the-shelf allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics Inc. MiNK Therapeutics Inc. was incorporated in 2017 and is based in New York New York.
View LessINKT | US
Risk
108.1
Sharpe
0.05
Luna's Score
43/100
Recommendation
Sell
Luna says (INKT | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
126.5%1 month
108.1%3 months
101.0%6 months
83.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
10.05
Debt to equity
-0.27
Debt to assets
0.43
Ent. to EBITDA
-3.67
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-17.25M
MarketCap
432.96M
MarketCap(USD)
432.96M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-1.24K
Short ratio
2.31
Short perc.
0.33
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
4.45
Range1M
6.30
Range3M
8.45
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.50
Price X volume
381.30K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.67 | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 10.05 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 101.01 | - | - |
| Debt to Equity | -0.27 | - | - |
| Debt to Assets | 0.43 | - | - |
| Market Cap | 432.96M | - | - |
